Tuberc Respir Dis > Volume 40(2); 1993 > Article
Tuberculosis and Respiratory Diseases 1993;40(2):171-176.
DOI:    Published online April 1, 1993.
The clinical aspects of pneumonic patients with positive mycoplasma antibody.
Kyu Rok Yi, Jun Young Park, Sang Moo Lee, Hyoen Tae Kim, Soo Taek Uh, Yeon Tae Chung, Yong Hoon Kim, Choon Sik Park
DePartment of Internal Medicine, College of Medicine, Soonchunhyang University, Seoul, Korea
Mycoplasma pneumonia (M. pneumonia) is a major cause of atypical pneumonia, and its incidence is predominantly at childhood and early adulthood. In contrast, the incidence of adult patients with M. pneumonia has been known to below. Furthermore, the clinical aspects of M. pneumonia are different from those of community-acquired pneumonia. Thus, we evaluated the clinical aspects of M. pneumonia in the adult patients.
Mycoplasma antibody and cold agglutination tests were performed in patients with clinically suspected pneumonia who had abnormal infiltrations on chest P.A. The 12 patients with pneumonia, who fulfilled entry criteria of more than 1:64 of cold agglutination titer and 1:40 of mycoplasma antibody titer or four.fold increase of mycoplasma antibody titer during one week, were analy zed in terms of clinical aspects.
1) T welve patients, male 3 and female 9, were included in this study. The peak incidence was teenager. 2) M. pneumonia occured perennially, but predominantly between June to October in eight patients. 3) The main symptoms were fever , coughing, sputum. 4) The main patterns of chest P.A were bronchopneumoina in 8 cases, and involved lesion were nearly both lower lobe.
The clinical aspects with Mycoplasma pneumonia in adult patients were different from those of community acquired pneumonia.
Key Words: Mycoplasma pneumonia, Mycoplasma antibody

Article category

Browse all articles >


Browse all articles >

Editorial Office
101-605, 58, Banpo-daero, Seocho-gu (Seocho-dong, Seocho Art-Xi), Seoul 06652, Korea
Tel: +82-2-575-3825, +82-2-576-5347    Fax: +82-2-572-6683    E-mail:                

Copyright © 2024 by The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved.

Developed in M2PI

Close layer
prev next